- Home
- TECX
as 11-07-2024 4:00pm EST
Stocks
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease.
| Founded: | 2019 | Country: | United States |
| Employees: | N/A | City: | WATERTOWN |
| Market Cap: | 602.3M | IPO Year: | 2018 |
| Target Price: | $60.00 | AVG Volume (30 days): | 117.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.11 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.40 - $46.91 | Next Earning Date: | 11-24-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Tectonic Therapeutic Inc. Common Stock News
TECX Breaking Stock News: Dive into TECX Ticker-Specific Updates for Smart Investing
Simply Wall St.
11 days ago
Tectonic Therapeutic Independent Director Acquires 7.0% More Stock
GlobeNewswire
16 days ago
Tectonic Therapeutic to Present Phase 1a Data at AHA 2024
Argus Research
a month ago
Daily – Vickers Top Buyers & Sellers for 09/27/2024
Simply Wall St.
a month ago
Tectonic Therapeutic (NASDAQ:TECX) Is In A Good Position To Deliver On Growth Plans
GlobeNewswire
2 months ago
Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45
GlobeNewswire
3 months ago
Tectonic Therapeutic to Participate in September Investor Conferences
GlobeNewswire
3 months ago
Tectonic Therapeutic Announces Second Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire
3 months ago
Tectonic Therapeutic Announces US IND Clearance for Lead Program, TX45
Compare TECX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TECX Tectonic Therapeutic Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.